Analysis quality of life of Crohn’s disease patients based on the sf-36 questionnaire
-
Published:2024-01-18
Issue:1
Volume:
Page:92-98
-
ISSN:1682-8658
-
Container-title:Experimental and Clinical Gastroenterology
-
language:
-
Short-container-title:ECG
Author:
Khavkin A. I.1ORCID, Novikova V. P.2ORCID, Nalyotov A. V.3ORCID, Iotova Yu. T.2ORCID, Bogdanova E. A.2ORCID, Yablokova E. A.4ORCID, Erokhina M. I.5ORCID
Affiliation:
1. Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region; Belgorod National Research University 2. St. Petersburg State Pediatric Medical University 3. M. Gorky Donetsk State Medical University 4. Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region; Sechenov University 5. Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region
Abstract
Introduction: the relevance of the problem of quality of life (QOL) in Crohn’s disease (CD) is due to the increasing prevalence of inflammatory bowel diseases (IBD), the progressive course of this disease, frequent exacerbations, the presence of complications, which leads to early disability and increases the risk of surgical interventions. Purpose: To analyze publications describing the quality of life of patients with Crohn’s disease. Materials and methods: A search was conducted for publications carried out from 2003 to 2023 on databases using keywords: inflammatory bowel diseases (IBD), quality of life (QOL), Crohn’s disease, SF-36 questionnaire. X articles were found. X papers were selected for the review, where the SF-36 questionnaire was the main tool for studying the quality of life of patients. 13 papers were found and selected for the review, where the SF-36 questionnaire was the main tool for studying the quality of life of patients. Result: Most researchers had convincing confirmation that the quality of life of patients with CD is worse during exacerbation on all studied scales in comparison with healthy people, while during remission it does not differ from the quality of life of people without this disease. Factors that improve and worsen QOL in CD have been identified. Conclusion: in people of different ages with the active course of Crohn’s disease, the quality of life is significantly impaired, but the quality of life of children and adolescents requires additional study.
Publisher
LLC Global Media Technology
Reference30 articles.
1. Kulygina Y.A., Osipenko M.F. Quality of life of patients with inflammatory bowel diseases and irritable bowel syndrome: what is common? Efficient Pharmacotherapy. 2023; 19 (8): 50-54. (in Russ.) doi: 10.33978/2307-3586-2023-19-8-50-54.@@ Kulygina Yu.A., Osipenko M.F. Kachestvo zhizni bol'nykh s vospalitel'nymi zabolevaniyami kishechnika i sindromom razdrazhennogo kishechnika: chto obshchego? Effektivnaya farmakoterapiya. 2023; 19 (8): 50-54. doi: 10.33978/2307-3586-2023-19-8-50-54. 2. Knyazev, O.V., Boldyreva, O.N., Parfenov, A.I., Efremov, L.I., Huseynzadeh, M. G., Ruchkina, I. N., Gribanov, I. I. Quality of life in patients with inflammatory bowel diseases. Experimental and clinical gastroenterology. 2011;(9):18-25. (in Russ.)@@ Knyazev, O.V., Boldyreva, O.N., Parfenov, A.I., Efremov, L.I., Guseinzade, M.G., Ruchkina, I.N., Gribanov, I.I. Kachestvo zhizni bol'nykh vospalitel'nymi zabolevaniyami kishechnika. Eksperimental'naya i klinicheskaya gastroenterologiya. 2011 ;(9):18-25. 3. Bezrukova E.V., Grigorieva N.O. Assessment of the quality of life of patients with pathology of ENT organs.Russian otorhinolaryngology. 2011;(2): 21-45. (in Russ.)@@ Bezrukova E.V., Grigor'eva N.O. Otsenka kachestva zhizni patsientov s patologiei lor organov. Rossiiskaya otorinolaringologiya. 2011;(2): 21-45 4. Seyedyan S.S., Nokhostin F., Malamir M.D. Review of methods of diagnosis, prevention and treatment of inflammatory bowel diseases. J Med Life. 2019 Apr-Jun;12(2):113-122. doi: 10.25122/jml-2018-0075. 5. Feroz S.H., Ahmed A., Muralidharan A., Tirunavukarasu P. Comparison of the effectiveness of various methods of treatment of Crohn’s perianal fistula: an overview. Cureus. 2020 Dec 3;12(12):e11882. doi: 10.7759/cureus.11882.
|
|